Summary
CME Group Inc. reported solid financial results for the nine months ended September 30, 2021, with total revenues reaching $3.54 billion, a decrease of 6% compared to the same period in 2020, primarily driven by lower clearing and transaction fees. However, the company demonstrated strong operational efficiency, with total expenses decreasing by 8% year-over-year. Net income attributable to CME Group saw a significant increase of 20% to $2.01 billion, bolstered by substantial non-operating income, including a notable gain from the deconsolidation of its optimization business into the OSTTRA joint venture. Diluted earnings per share also grew by 19% to $5.60. The company's balance sheet remains robust, with total assets increasing significantly to $186.8 billion, largely due to a substantial rise in performance bonds and guaranty fund contributions. This increase reflects the central role CME Group plays in managing financial market risks. Despite increased debt, particularly short-term debt, the company's overall financial position appears stable, supported by strong cash flows from operations. Investors should note the strategic move into the OSTTRA joint venture, which is expected to contribute to future earnings through equity method accounting.
Financial Highlights
46 data points| Revenue | $1.11B |
| Operating Expenses | $496.20M |
| Operating Income | $613.70M |
| Net Income | $926.30M |
| EPS (Basic) | $2.59 |
| EPS (Diluted) | $2.58 |
| Shares Outstanding (Basic) | 358.36M |
| Shares Outstanding (Diluted) | 358.99M |
Key Highlights
- 1Net income attributable to CME Group increased by 20% to $2.01 billion for the first nine months of 2021, compared to $1.68 billion in the prior year period.
- 2Diluted earnings per share grew by 19% to $5.60 for the first nine months of 2021, up from $4.70 in the same period of 2020.
- 3Total revenues for the nine months ended September 30, 2021, were $3.54 billion, a decrease of 6% from $3.79 billion in the prior year, primarily due to lower clearing and transaction fees.
- 4Total expenses decreased by 8% to $1.53 billion for the first nine months of 2021, reflecting improved operational efficiency.
- 5A significant gain of $343.5 million was recognized from the deconsolidation of the optimization business into the OSTTRA joint venture, contributing to strong non-operating income.
- 6Interest rate contract volumes increased substantially in the third quarter of 2021, driven by higher market volatility.
- 7The company's balance sheet shows a large increase in 'Performance bonds and guaranty fund contributions' to $149.2 billion as of September 30, 2021, reflecting its role as a clearing house.